Karin Jordan

1993–2025 年に発表

68
論文数
18,057
被引用数
52
h 指数
65
i10 指数

被引用数

Karin Jordan の年別被引用数1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 2 件1997 年: 被引用 5 件1998 年: 被引用 7 件1999 年: 被引用 3 件2000 年: 被引用 5 件2001 年: 被引用 2 件2002 年: 被引用 3 件2003 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 2 件2006 年: 被引用 3 件2007 年: 被引用 14 件2008 年: 被引用 16 件2009 年: 被引用 11 件2010 年: 被引用 28 件2011 年: 被引用 21 件2012 年: 被引用 32 件2013 年: 被引用 61 件2014 年: 被引用 64 件2015 年: 被引用 81 件2016 年: 被引用 45 件2017 年: 被引用 80 件2018 年: 被引用 102 件2019 年: 被引用 458 件2020 年: 被引用 656 件2021 年: 被引用 739 件2022 年: 被引用 597 件2023 年: 被引用 524 件2024 年: 被引用 870 件2025 年: 被引用 376 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,350 件、この内訳の 16.8%中国: 引用元論文 719 件、この内訳の 9%イタリア: 引用元論文 612 件、この内訳の 7.6%イギリス: 引用元論文 509 件、この内訳の 6.3%ドイツ: 引用元論文 421 件、この内訳の 5.3%フランス: 引用元論文 375 件、この内訳の 4.7%スペイン: 引用元論文 305 件、この内訳の 3.8%日本: 引用元論文 288 件、この内訳の 3.6%カナダ: 引用元論文 287 件、この内訳の 3.6%オランダ: 引用元論文 264 件、この内訳の 3.3%スイス: 引用元論文 258 件、この内訳の 3.2%オーストラリア: 引用元論文 241 件、この内訳の 3%
0%16.8%その他 29.8%

分野

  • Medicine87.3%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Immunology and Microbiology1.4%
  • Neuroscience0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Engineering0.5%
  • その他2.5%

トピック

  • Cancer Immunotherapy and Biomarkers9.4%
  • Colorectal Cancer Treatments and Studies3.3%
  • CAR-T cell therapy research3.3%
  • Chemotherapy-induced cardiotoxicity and mitigation2.8%
  • Cancer survivorship and care2.6%
  • Nausea and vomiting management2.5%
  • その他76.1%

共著者

全論文

検索で開く
  1. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , - Annals of Oncology 2022 被引用: 1,154

  2. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

    著者: , , , , , , - Annals of Oncology 2020 被引用: 487

  3. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 1,003

  4. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , - Annals of Oncology 2017 被引用: 2,354

  5. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

    著者: , , , , , , , , , , , , , - Annals of Oncology 2023 被引用: 384

  6. Bone health in cancer: ESMO Clinical Practice Guidelines

    著者: , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 518

  7. Integration of oncology and palliative care: a Lancet Oncology Commission

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2018 被引用: 834

  8. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

    著者: , , , , , , , , , , - Annals of Oncology 2020 被引用: 324

  9. Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment

    著者: , , , , , , , , - Annals of Oncology 2020 被引用: 551

  10. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines†

    著者: , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 472

  11. Antiemetics: ASCO Guideline Update

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 被引用: 457

  12. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karin Jordan, Andrey Meshcheryakov, Demetris Papamichail, Per Pfeiffer, Ioannis Souglakos, Serdar Turhal, Andrés Cervantes - Annals of Oncology 2012 被引用: 1,534

  13. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ana Zilić, Karin Jordan, Florian Scotté - ESMO Open 2024 被引用: 141

  14. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 635

  15. Corrections to “Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    著者: , , , , , , - Annals of Oncology 2018 被引用: 430

  16. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

    著者: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2016 被引用: 580

  17. Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management

    著者: , , - Therapeutic Advances in Medical Oncology 2009 被引用: 426

  18. Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines

    著者: , , , , , , , , , - Annals of Oncology 2018 被引用: 170

  19. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

    著者: , , , , , , , , - Annals of Oncology 2017 被引用: 229

  20. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dirk De Ruysscher, Elisabeth G.E. de Vries, Rebecca Dent, Jean-Yves Douillard, Domenico D’Ugo, Rafał Dziadziuszko, Corinne Faivre‐Finn, Eudald Felip, M.C. Garassino, Pilar Garrido, Nicolas Girard, Rob Glynne‐Jones, V. Golfinopoulos, John B.A.G. Haanen, E. Hamilton, Pasi A. Jänne, Karin Jordan, Ravindran Kanesvaran, S.B. Kim, Uwe G. Liebert, F. Lordick, Jean-Pascal Machiels, Olivier Michielin, T.S.K. Mok, Gilberto Morgan, Radka Obermannová, K. Park, Antonio Passaro, George Pentheroudakis, Solange Peters, Martin Reck, Romane Soler, Florian Scotté, Suresh Senan, Cristiana Sessa, Elizabeth Smyth, Ross A. Soo, Jean‐Charles Soria, Jennifer O. Spicer, Florian Strasser, Josep Tabernero, Dongling Tan, Dario Trapani, Eric Van Cutsem, Henk van Halteren, Paul E. Van Schil, Giulia Veronesi, Jing Yang, Giulia Veronesi, Jing Yang - Annals of Oncology 2020 被引用: 313

  21. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

    著者: , , , , , , , , , - Annals of Oncology 2017 被引用: 112

  22. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆

    著者: , , , , , , , - Annals of Oncology 2020 被引用: 172

  23. Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

    著者: , , , , , , , , , , , , , , , , - Annals of Oncology 2020 被引用: 89

  24. Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer

    著者: , , , , , , , - Annals of Oncology 2020 被引用: 106